{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:29:08Z","timestamp":1790076548767,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"9-10","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T00:00:00Z","timestamp":1563408000000},"content-version":"am","delay-in-days":351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI072613"],"award-info":[{"award-number":["R01AI072613"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI072613"],"award-info":[{"award-number":["R01AI072613"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ijpara.2018.04.002","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T08:40:47Z","timestamp":1528274447000},"page":"773-783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Prospects of developing a prophylactic vaccine against human lymphatic filariasis \u2013 evaluation of protection in non-human primates"],"prefix":"10.1016","volume":"48","author":[{"given":"Vishal","family":"Khatri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchan","family":"Vishnoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta","family":"von Gegerfelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Gittens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramaswamy","family":"Kalyanasundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpara.2018.04.002_b0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1475-2883-6-10","article-title":"Pan LF-ELISA using BmR1 and BmSXP recombinant antigens for detection of lymphatic filariasis","volume":"6","author":"Abdul Rahman","year":"2007","journal-title":"Filaria J."},{"key":"10.1016\/j.ijpara.2018.04.002_b0010","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/infdis\/jir545","article-title":"Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic","volume":"204","author":"Ahmad","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpara.2018.04.002_b0015","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1017\/S0022149X10000799","article-title":"A combination of two Brugia malayi filarial vaccine candidate antigens (BmALT-2 and BmVAH) enhances immune responses and protection in jirds","volume":"85","author":"Anand","year":"2011","journal-title":"J. Helminthol."},{"key":"10.1016\/j.ijpara.2018.04.002_b0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.actatropica.2008.04.018","article-title":"Comparison of immunogenicity, protective efficacy of single and cocktail DNA vaccine of Brugia malayi abundant larval transcript (ALT-2) and thioredoxin peroxidase (TPX) in mice","volume":"107","author":"Anand","year":"2008","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpara.2018.04.002_b0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/2230-8598.108383","article-title":"Assessing coverage of mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka","volume":"2","author":"Anil","year":"2012","journal-title":"Int. J. Med. Public Health"},{"key":"10.1016\/j.ijpara.2018.04.002_b0030","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2478\/s11686-013-0160-8","article-title":"Immune responses of B. malayi thioredoxin (TRX) and venom allergen homologue (VAH) chimeric multiple antigen for lymphatic filariasis","volume":"58","author":"Anugraha","year":"2013","journal-title":"Acta Parasitol."},{"key":"10.1016\/j.ijpara.2018.04.002_b0035","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ijpara.2014.05.003","volume":"44","author":"Arumugam","year":"2014","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpara.2018.04.002_b0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-3024.2011.01350.x","article-title":"Future prospects and challenges of vaccines against filariasis","volume":"34","author":"Babayan","year":"2012","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.ijpara.2018.04.002_b0045","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.vaccine.2016.03.016","article-title":"Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigen","volume":"34","author":"Baldwin","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpara.2018.04.002_b0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/lrb.2009.0022","article-title":"Lymphatics in human lymphatic filariasis: in vitro models of parasite-induced lymphatic remodeling","volume":"7","author":"Bennuru","year":"2009","journal-title":"Lymphat. Res. Biol."},{"key":"10.1016\/j.ijpara.2018.04.002_b0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4172\/2161-1165.1000252","article-title":"Mass drugs administration in India \u2013 a failure story","volume":"6","author":"Bhattacharjee","year":"2016","journal-title":"Epidemiology (Sunnyvale)"},{"key":"10.1016\/j.ijpara.2018.04.002_b0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1756-3305-7-46","article-title":"Seventh meeting of the Global Alliance to Eliminate Lymphatic Filariasis: reaching the vision by scaling up, scaling down, and reaching out","volume":"7","author":"Brady","year":"2014","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ijpara.2018.04.002_b0065","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/s13071-014-0466-x","article-title":"The global distribution and transmission limits of lymphatic filariasis: past and present","volume":"7","author":"Cano","year":"2014","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ijpara.2018.04.002_b0070","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1038\/cti.2016.63","article-title":"A structure- function approach to optimizing TLR4 ligands for human vaccines","volume":"5","author":"Carter","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.ijpara.2018.04.002_b0075","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s00436-017-5593-9","article-title":"Improving the efficacy of a prophylactic vaccine formulation against lymphatic filariasis","volume":"116","author":"Chauhan","year":"2017","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpara.2018.04.002_b0080","first-page":"CD003753","article-title":"Albendazole for lymphatic filariasis","volume":"19","author":"Critchley","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijpara.2018.04.002_b0085","doi-asserted-by":"crossref","first-page":"e34077","DOI":"10.1371\/journal.pone.0034077","article-title":"Biochemical characterization and evaluation of a Brugia malayi small heat shock protein as a vaccine against lymphatic filariasis","volume":"7","author":"Dakshinamoorthy","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpara.2018.04.002_b0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vaccine.2013.10.083","article-title":"Evaluating the efficacy of rBmHATalphac as a multivalent vaccine against lymphatic filariasis in experimental animals and optimizing the adjuvant formulation","volume":"32","author":"Dakshinamoorthy","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpara.2018.04.002_b0095","doi-asserted-by":"crossref","first-page":"e77394","DOI":"10.1371\/journal.pone.0077394","article-title":"Large extracellular loop of tetraspanin as a potential vaccine candidate for filariasis","volume":"8","author":"Dakshinamoorthy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpara.2018.04.002_b0100","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.vaccine.2012.09.055","article-title":"Multivalent fusion protein vaccine for lymphatic filariasis","volume":"31","author":"Dakshinamoorthy","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpara.2018.04.002_b0105","doi-asserted-by":"crossref","first-page":"e112982","DOI":"10.1371\/journal.pone.0112982","article-title":"Evaluation of a multivalent vaccine against lymphatic filariasis in rhesus macaque model","volume":"9","author":"Dakshinamoorthy","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpara.2018.04.002_b0110","first-page":"1","article-title":"Prospects of elimination of lymphatic filariasis in India","volume":"32","author":"Das","year":"2002","journal-title":"ICMR Bull."},{"key":"10.1016\/j.ijpara.2018.04.002_b0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0047-0740(80)90028-5","article-title":"Vaccination against filarial worms using radiation-attenuated vaccines","volume":"7","author":"Denham","year":"1980","journal-title":"Int. J. Nucl. Med. Biol."},{"key":"10.1016\/j.ijpara.2018.04.002_b0120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/expr.1998.4300","article-title":"Histopathological, lymphoscintigraphical, and immunological changes in the inguinal lymph nodes of rhesus monkeys during the early course of infection with Brugia malayi","volume":"89","author":"Dennis","year":"1998","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpara.2018.04.002_b0125","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","article-title":"AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijpara.2018.04.002_b0130","first-page":"289","article-title":"Differential recognition of microfilarial chitinase, a transmission-blocking vaccine candidate antigen, by sera from patients with Brugian and Bancroftian filariasis","volume":"53","author":"Dissanayake","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpara.2018.04.002_b0135","doi-asserted-by":"crossref","first-page":"e1807","DOI":"10.1371\/journal.pntd.0001807","article-title":"Secondary mapping of lymphatic filariasis in Haiti-definition of transmission foci in low-prevalence settings","volume":"6","author":"Drexler","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijpara.2018.04.002_b0140","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.epidem.2017.02.002","article-title":"Measuring and modelling the effects of systematic non-adherence to mass drug administration","volume":"18","author":"Dyson","year":"2017","journal-title":"Epidemics"},{"key":"10.1016\/j.ijpara.2018.04.002_b0145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-90-481-9078-2_14","article-title":"Synthetic and natural TLR4 agonists as safe and effective vaccine adjuvants","volume":"53","author":"Fox","year":"2010","journal-title":"Subcell Biochem."},{"key":"10.1016\/j.ijpara.2018.04.002_b0150","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1128\/IAI.72.8.4707-4715.2004","article-title":"A novel phage display based screening to identify potential vaccine candidate antigens of the filarial parasite Brugia malayi","volume":"72","author":"Gnanasekar","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijpara.2018.04.002_b0155","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/10425170701517614","article-title":"Identification and cloning of a novel tetraspanin (TSP) homologue from Brugia malayi","volume":"19","author":"Gnanasekar","year":"2008","journal-title":"DNA Seq."},{"key":"10.1016\/j.ijpara.2018.04.002_b0160","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2174\/0929866511320080004","article-title":"Prediction of Brugia malayi antigenic peptides: candidates for synthetic vaccine design against lymphatic filariasis","volume":"20","author":"Gomase","year":"2013","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.ijpara.2018.04.002_b0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0166-6851(97)00050-9","article-title":"Differentially expressed, abundant trans-spliced cDNAs from larval Brugia malayi","volume":"87","author":"Gregory","year":"1997","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpara.2018.04.002_b0170","doi-asserted-by":"crossref","first-page":"e0164991","DOI":"10.1371\/journal.pone.0164991","article-title":"Immunization with Brugia malayi myosin as heterologous DNA prime protein boost induces protective immunity against B. malayi infection in Mastomys coucha","volume":"11","author":"Gupta","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpara.2018.04.002_b0175","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0001-706X(03)00159-1","article-title":"Detection of codon for amino acid 200 in isotype 1 beta-tubulin gene of Wuchereria bancrofti isolates, implicated in resistance to benzimidazoles in other nematodes","volume":"88","author":"Hoti","year":"2003","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpara.2018.04.002_b0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1079\/BER200078","article-title":"Detection of Brugia malayi in laboratory and wild-caught Mansonioides mosquitoes (Diptera: Culicidae) using Hha I PCR assay","volume":"91","author":"Hoti","year":"2001","journal-title":"Bull. Entomol. Res."},{"key":"10.1016\/j.ijpara.2018.04.002_b0185","first-page":"45","article-title":"Multivalent vaccine formulation with BmVAL-1 and BmALT-2 confer significant protection against challenge infections with Brugia malayi in mice and jirds","volume":"2011","author":"Kalyanasundaram","year":"2011","journal-title":"Res. Rep. Trop. Med."},{"key":"10.1016\/j.ijpara.2018.04.002_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002447","article-title":"A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis","volume":"7","author":"Krentel","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijpara.2018.04.002_b0195","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1590\/S0037-86822012000600017","article-title":"Adverse reactions following mass drug administration with diethylcarbamazine in lymphatic filariasis endemic areas in the Northeast of Brazil","volume":"45","author":"Lima","year":"2012","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.ijpara.2018.04.002_b0200","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1017\/S0022149X16000055","article-title":"Epitope mapping of Brugia malayi ALT-2 and the development of a multi-epitope vaccine for lymphatic filariasis","volume":"91","author":"Madhumathi","year":"2017","journal-title":"J. Helminthol."},{"key":"10.1016\/j.ijpara.2018.04.002_b0205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2229-5070.105175","article-title":"Factors determining noncompliance to mass drug administration for lymphatic filariasis elimination","volume":"2","author":"Nujum","year":"2012","journal-title":"Trop. Parasitol."},{"key":"10.1016\/j.ijpara.2018.04.002_b0210","unstructured":"National Vector Borne Disease Control Program (NVBDCP). National Roadmap for elimination of lymphatic filariasis (ELF). Delhi: Directorate of National Vector Borne Disease Control Program. Available at: http:\/\/nvbdcp.gov.in\/Doc\/National-Roadmap-ELF.pdf. Accessed on: June 8, 2017."},{"key":"10.1016\/j.ijpara.2018.04.002_b0215","doi-asserted-by":"crossref","first-page":"e3319","DOI":"10.1371\/journal.pntd.0003319","article-title":"Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease","volume":"8","author":"Ramaiah","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijpara.2018.04.002_b0220","series-title":"Communicable Diseases of the Developing World. Topics in Medicinal Chemistry","first-page":"97","article-title":"Lymphatic filariasis: current status of elimination using chemotherapy and the need for a vaccine","author":"Kalyanasundaram","year":"2016"},{"key":"10.1016\/j.ijpara.2018.04.002_b0225","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1128\/JCM.00969-06","article-title":"Detection of Brugia parasite DNA in human blood by real-time PCR","volume":"44","author":"Rao","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijpara.2018.04.002_b0230","first-page":"20628","article-title":"Two decades of antifilarial drug discovery: a review","volume":"7","author":"Sangshetti","year":"2017","journal-title":"R. Soc. Chem."},{"key":"10.1016\/j.ijpara.2018.04.002_b0235","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/tropej\/fmt101","article-title":"Persistence of lymphatic filarial infection in the paediatric population of rural community, after six rounds of annual mass drug administrations","volume":"60","author":"Sunish","year":"2014","journal-title":"J. Trop. Pediatr."},{"key":"10.1016\/j.ijpara.2018.04.002_b0240","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0001-706X(02)00267-X","article-title":"A simple and rapid DNA extraction method for the detection of Wuchereria bancrofti infection in the vector mosquito, Culex quinquefasciatus by Ssp I PCR assay","volume":"86","author":"Vasuki","year":"2003","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpara.2018.04.002_b0245","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1016\/j.vaccine.2008.08.073","article-title":"Vaccination with 73kDa recombinant heavy chain myosin generates high level of protection against Brugia malayi challenge in jird and mastomys models","volume":"26","author":"Vedi","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpara.2018.04.002_b0250","doi-asserted-by":"crossref","first-page":"e457","DOI":"10.1371\/journal.pntd.0000457","article-title":"Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis","volume":"3","author":"Veerapathran","year":"2009","journal-title":"PLoS Negl. Trop. Dis."}],"updated-by":[{"DOI":"10.1016\/j.ijpara.2018.09.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000}}],"container-title":["International Journal for Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020751918301188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020751918301188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T00:58:18Z","timestamp":1693702698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0020751918301188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":50,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0020751918301188"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpara.2018.04.002","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ijpara.2018.09.001","asserted-by":"object"}]},"ISSN":["0020-7519"],"issn-type":[{"value":"0020-7519","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospects of developing a prophylactic vaccine against human lymphatic filariasis \u2013 evaluation of protection in non-human primates","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpara.2018.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Australian Society for Parasitology. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}